このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Aadi Bioscience マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Dave Lennon
最高経営責任者
US$2.1m
報酬総額
| CEO給与比率 | 7.5% |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 2.6yrs |
| 取締役会の平均在任期間 | 3.1yrs |
経営陣の近況
Recent updates
Lacklustre Performance Is Driving Aadi Bioscience, Inc.'s (NASDAQ:AADI) 27% Price Drop
Jul 03
Will Aadi Bioscience (NASDAQ:AADI) Spend Its Cash Wisely?
Jul 02Analyst Forecasts Just Became More Bearish On Aadi Bioscience, Inc. (NASDAQ:AADI)
May 10Improved Revenues Required Before Aadi Bioscience, Inc. (NASDAQ:AADI) Stock's 28% Jump Looks Justified
Mar 07Here's Why We're Watching Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation
Feb 12Why Investors Shouldn't Be Surprised By Aadi Bioscience, Inc.'s (NASDAQ:AADI) 48% Share Price Plunge
Dec 16Analysts Have Lowered Expectations For Aadi Bioscience, Inc. (NASDAQ:AADI) After Its Latest Results
Nov 10Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Oct 03Here's Why We're Not Too Worried About Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation
Jun 28Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Mar 04Aadi Bioscience highlights combination of KRAS inhibitors and nab-sirolimus for tumors
Oct 12A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)
Sep 28Aadi Bioscience: Taking mTOR Inhibition To The Next Level
Sep 21Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Jul 06Aadi Bioscience to enter Russell 2000 and Russell 3000 indexes
Jun 23What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today
Nov 27Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
Nov 25CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$69m |
| Dec 31 2023 | US$2m | US$160k | -US$66m |
報酬と市場: Daveの 総報酬 ($USD 2.14M ) は、 US市場 ($USD 681.57K ) の同規模の企業の平均を上回っています。
報酬と収益: Daveの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Dave Lennon (53 yo)
less than a year
在職期間
US$2,135,687
報酬
Mr. David J. Lennon, Ph.D. also known as Dave, is the Treasurer at Alliance for Regenerative Medicine from April, 2022. He is the CEO of Satellite Bio. He serves as President and CEO & Director at Aadi Bio...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder & Executive Chairman | 12.9yrs | US$2.16m | 7.36% $ 3.5m | |
| President | less than a year | US$2.14m | データなし | |
| CFO, Treasurer | 2.8yrs | US$1.97m | 0% $ 0 | |
| Chief Medical Officer | 2.9yrs | US$1.48m | 0.012% $ 5.8k | |
| Senior VP of Legal & General Counsel | 2.6yrs | データなし | データなし | |
| Senior VP of Human Resources & Chief Human Resources Officer | 2.3yrs | データなし | データなし | |
| Chief Technical Operations Officer | 2.1yrs | データなし | 0.41% $ 193.0k |
2.6yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: AADIの経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder & Executive Chairman | 12.9yrs | US$2.16m | 7.36% $ 3.5m | |
| President | less than a year | US$2.14m | データなし | |
| Independent Chairman of the Board | 3.1yrs | US$258.91k | 0.080% $ 38.0k | |
| Independent Director | 3yrs | US$240.91k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$235.91k | 0.0046% $ 2.2k | |
| Independent Director | 3.1yrs | US$227.41k | 0% $ 0 | |
| Independent Director | 7.6yrs | US$240.91k | 0% $ 0 | |
| Independent Director | 1.5yrs | US$345.60k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$225.41k | 0% $ 0 |
3.1yrs
平均在職期間
53yo
平均年齢
経験豊富なボード: AADIの 取締役会 は 経験豊富 であると考えられます ( 3年の平均在任期間)。